|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: TRPM8 |
Gene summary for TRPM8 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | TRPM8 | Gene ID | 79054 |
| Gene name | transient receptor potential cation channel subfamily M member 8 | |
| Gene Alias | LTRPC6 | |
| Cytomap | 2q37.1 | |
| Gene Type | protein-coding | GO ID | GO:0001659 | UniProtAcc | Q7Z2W7 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 79054 | TRPM8 | HCC1 | Human | Liver | HCC | 6.61e-04 | 1.90e+00 | 0.5336 |
| 79054 | TRPM8 | HCC2 | Human | Liver | HCC | 2.58e-04 | 6.72e-01 | 0.5341 |
| 79054 | TRPM8 | HCC5 | Human | Liver | HCC | 1.63e-03 | 1.64e+00 | 0.4932 |
| 79054 | TRPM8 | S027 | Human | Liver | HCC | 3.60e-14 | 7.39e-01 | 0.2446 |
| 79054 | TRPM8 | S028 | Human | Liver | HCC | 4.21e-05 | 3.30e-01 | 0.2503 |
| 79054 | TRPM8 | S029 | Human | Liver | HCC | 6.22e-06 | 3.56e-01 | 0.2581 |
| Page: 1 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Prostate |  | BPH: Benign Prostatic Hyperplasia |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:000926611 | Liver | HCC | response to temperature stimulus | 101/7958 | 178/18723 | 8.55e-05 | 7.48e-04 | 101 |
| GO:010610611 | Liver | HCC | cold-induced thermogenesis | 76/7958 | 144/18723 | 8.07e-03 | 3.18e-02 | 76 |
| GO:012016111 | Liver | HCC | regulation of cold-induced thermogenesis | 76/7958 | 144/18723 | 8.07e-03 | 3.18e-02 | 76 |
| GO:199084511 | Liver | HCC | adaptive thermogenesis | 81/7958 | 157/18723 | 1.32e-02 | 4.72e-02 | 81 |
| GO:000926615 | Prostate | Tumor | response to temperature stimulus | 59/3246 | 178/18723 | 2.14e-07 | 5.21e-06 | 59 |
| GO:00094099 | Prostate | Tumor | response to cold | 17/3246 | 49/18723 | 2.61e-03 | 1.43e-02 | 17 |
| GO:01201623 | Prostate | Tumor | positive regulation of cold-induced thermogenesis | 28/3246 | 97/18723 | 3.35e-03 | 1.74e-02 | 28 |
| GO:19908453 | Prostate | Tumor | adaptive thermogenesis | 41/3246 | 157/18723 | 3.63e-03 | 1.86e-02 | 41 |
| GO:00016593 | Prostate | Tumor | temperature homeostasis | 44/3246 | 174/18723 | 5.04e-03 | 2.45e-02 | 44 |
| GO:01061064 | Prostate | Tumor | cold-induced thermogenesis | 37/3246 | 144/18723 | 7.29e-03 | 3.25e-02 | 37 |
| GO:01201614 | Prostate | Tumor | regulation of cold-induced thermogenesis | 37/3246 | 144/18723 | 7.29e-03 | 3.25e-02 | 37 |
| Page: 1 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| TRPM8 | SNV | Missense_Mutation | novel | c.2682N>C | p.Gln894His | p.Q894H | Q7Z2W7 | protein_coding | tolerated(0.62) | benign(0) | TCGA-A7-A4SF-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | CR |
| TRPM8 | SNV | Missense_Mutation | novel | c.374N>G | p.Asp125Gly | p.D125G | Q7Z2W7 | protein_coding | tolerated(0.07) | benign(0.112) | TCGA-A8-A08B-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR |
| TRPM8 | SNV | Missense_Mutation | rs202194673 | c.64N>T | p.Arg22Trp | p.R22W | Q7Z2W7 | protein_coding | deleterious(0) | benign(0.23) | TCGA-A8-A09Q-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Hormone Therapy | anastrozole | SD |
| TRPM8 | SNV | Missense_Mutation | c.2032N>G | p.Leu678Val | p.L678V | Q7Z2W7 | protein_coding | deleterious(0) | benign(0.031) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
| TRPM8 | SNV | Missense_Mutation | c.2216N>T | p.Ser739Phe | p.S739F | Q7Z2W7 | protein_coding | tolerated(0.33) | probably_damaging(0.996) | TCGA-BH-A0HP-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | doxorubicin | SD | |
| TRPM8 | SNV | Missense_Mutation | novel | c.3161N>T | p.Ala1054Val | p.A1054V | Q7Z2W7 | protein_coding | deleterious(0.02) | benign(0.227) | TCGA-BH-A0WA-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| TRPM8 | SNV | Missense_Mutation | rs778326469 | c.1394C>T | p.Ala465Val | p.A465V | Q7Z2W7 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-BH-A1F2-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
| TRPM8 | SNV | Missense_Mutation | c.1111N>C | p.Glu371Gln | p.E371Q | Q7Z2W7 | protein_coding | tolerated(0.07) | possibly_damaging(0.645) | TCGA-BH-A1F8-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
| TRPM8 | SNV | Missense_Mutation | c.247N>T | p.Ile83Phe | p.I83F | Q7Z2W7 | protein_coding | tolerated(0.52) | benign(0.015) | TCGA-D8-A1XQ-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
| TRPM8 | SNV | Missense_Mutation | c.459G>T | p.Lys153Asn | p.K153N | Q7Z2W7 | protein_coding | deleterious(0.05) | possibly_damaging(0.477) | TCGA-EW-A1J5-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| 79054 | TRPM8 | DRUGGABLE GENOME, ION CHANNEL, EXTERNAL SIDE OF PLASMA MEMBRANE | blocker | 135651503 | ||
| 79054 | TRPM8 | DRUGGABLE GENOME, ION CHANNEL, EXTERNAL SIDE OF PLASMA MEMBRANE | blocker | 135649885 | ||
| 79054 | TRPM8 | DRUGGABLE GENOME, ION CHANNEL, EXTERNAL SIDE OF PLASMA MEMBRANE | blocker | 178100954 | ||
| 79054 | TRPM8 | DRUGGABLE GENOME, ION CHANNEL, EXTERNAL SIDE OF PLASMA MEMBRANE | blocker | 178101078 | ||
| 79054 | TRPM8 | DRUGGABLE GENOME, ION CHANNEL, EXTERNAL SIDE OF PLASMA MEMBRANE | blocker | 135651438 | ANANDAMIDE | |
| 79054 | TRPM8 | DRUGGABLE GENOME, ION CHANNEL, EXTERNAL SIDE OF PLASMA MEMBRANE | activator | 135651519 | ||
| 79054 | TRPM8 | DRUGGABLE GENOME, ION CHANNEL, EXTERNAL SIDE OF PLASMA MEMBRANE | antagonist | 354702247 | ELISMETREP | |
| 79054 | TRPM8 | DRUGGABLE GENOME, ION CHANNEL, EXTERNAL SIDE OF PLASMA MEMBRANE | antagonist | 404859145 | ||
| 79054 | TRPM8 | DRUGGABLE GENOME, ION CHANNEL, EXTERNAL SIDE OF PLASMA MEMBRANE | D3263 | |||
| 79054 | TRPM8 | DRUGGABLE GENOME, ION CHANNEL, EXTERNAL SIDE OF PLASMA MEMBRANE | MENTHOL | MENTHOL | 17293875 |
| Page: 1 2 3 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |